Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Notified Body Numbers Continue To Fall

Executive Summary

The number of notified bodies in the EU medtech arena continues to drop, as predicted, as the tougher new requirements for these organizations take hold. Here's a look at the country-by-country details.

You may also be interested in...



What's Next For Notified Bodies: TEAM-NB President Discusses Challenges Ahead

A Q&A with Guy Buijzen, of TEAM-NB, on where things stand for notified bodies right now as the EU moves to adopt the new regulations for devices and diagnostics. The EU notified body association is redoubling efforts to prepare its members for the coming changes.

New EU Regulations: What Could Possibly Go Wrong?

How much faith do medtech regulatory experts have in the forthcoming medical device and IVD regulations and will they be ready on time? While the EU is making significant progress, experts continue to have serious concerns about implementation of the new regulations and the impact on industry.

New World Of Regulation Awaits IVD Companies In Europe From Coming Reforms

EU power players are currently negotiating vast changes to how in vitro diagnostics are regulated in Europe. The resulting system will involve a lot more external oversight than today for most IVDs. Here's a rundown of what to expect.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel